Article Text

Download PDFPDF
Coffee, pancreatic cancer, and K-rasmutations: updating the research agenda
  1. MIQUEL PORTA,
  2. NÚRIA MALATS,
  3. JUAN ALGUACIL,
  4. LAURA RUIZ,
  5. MANUEL JARIOD,
  6. ALFREDO CARRATO,
  7. JULI RIFÁ,
  8. LUISA GUARNER
  1. Institut Municipal d'Investigació Mèdica (IMIM), Carrer del Dr Aiguader 80, E-08003 Barcelona, Spain
  1. Professor Porta (mporta{at}imim.es)

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We very much appreciate the interest of Kuper and colleagues1 in our paper,2 and we thank them for raising several issues of relevance for research on pancreatic carcinogenesis and for epidemiological thinking on causality.

Risk of pancreatic cancer among heavy coffee drinkers and the “overall” risk

As mentioned in our paper2 (Introduction, second paragraph), the epidemiological evidence certainly includes the possibility that the risk of exocrine pancreatic cancer is slightly increased among people drinking large amounts of coffee. This conclusion has been achieved by several reviews of the literature and one meta-analysis.2 Figure 1 of Kuperet al is in line with such possibility. How much could “large amounts” be? It is hard to say, mostly because the actual composition of the beverage varies so much across countries, as do probably a number of factors with which coffee interacts to cause the increased risk. Specific studies are needed to clarify these issues, as we shall see immediately.

Figure 1

Consumption of coffee among cases of exocrine pancreatic cancer (EPC) and among referents with cancer of the extrahepatic biliary system (CEBS), benign biliary pathologies (BBP), and controls from Hospital del Mar. Information on amount of coffee was missing for two cases of EPC.

In principle, the previous sentences are compatible with another conclusion, which we consider fairly well established and that we also share with our colleagues1: the epidemiological evidence indicates that no overall association exists between coffee drinking and risk of exocrine pancreatic cancer (Introduction, second paragraph; Discussion, third paragraph).2 In table 1, we now present adjusted odds ratios for the entire group of 107 cases of pancreatic cancer, as compared with the three referent groups that our original paper mentioned (Discussion, second and third paragraphs).2 As can be seen (table 1, first and second columns), the overall risk estimates are very close to …

View Full Text

Footnotes

  • Funding: FIS (grant 95/0017) and CIRIT (1999 SGR 00241).